Clinical trials · Florida
Recurrent Glioblastoma, IDH-Wildtype clinical trials in Florida
We’re tracking 5 recruiting recurrent glioblastoma, idh-wildtype studies with a site in Florida — including Phase 1 and Phase 1/Phase 2 studies, each written for real people, not researchers.
Recruiting studies in Florida
- NCT07091864Recruiting
Using glucose monitors to manage blood sugar in glioblastoma
This study tests whether using continuous glucose monitors (which track blood sugar) can help manage high blood sugar in people newly diagnosed with glioblastoma. High blood sugar may be common in brain cancer patients, and the study aims to see if better sugar control can improve outcomes.
Jacksonville, FloridaAges 18 years+ - NCT06047379RecruitingPhase 1/Phase 2
Testing NEO212 for brain tumors and metastases
This trial tests a new drug called NEO212 for people with certain brain tumors (like astrocytoma or glioblastoma) or cancer that has spread to the brain from other parts of the body. The goal is to see if it is safe and if it can help shrink or control the tumors.
Boynton Beach, FloridaAges 18 years+ - NCT05432804RecruitingPhase 1/Phase 2
Selinexor added to temozolomide for recurring brain glioblastoma
This trial studies whether adding selinexor to the standard chemotherapy temozolomide (with radiation) can better treat glioblastoma that has come back after prior treatment. If you meet specific tumor, health, and lab requirements, the goal is to slow tumor growth or improve symptoms.
Coral Gables, FloridaAges 18 years+ - NCT05789394RecruitingPhase 1
Stem cell treatment for recurrent brain tumor surgery
This Phase 1 study tests an “allogenic” stem cell product made from donated fat tissue to treat recurrent glioblastoma or certain recurrent astrocytoma. It gives the treatment around the time of a repeat brain surgery, and focuses on safety while also studying why it might help.
Jacksonville, FloridaAges 18 years+ - NCT06860594RecruitingPhase 1
Triapine plus radiation for recurrent brain tumors
This trial tests whether adding an experimental drug called triapine to a second round of radiation therapy can help treat brain tumors that have come back after initial treatment. It may be a good option for people with recurrent glioblastoma or astrocytoma who meet safety criteria.
Coral Gables, FloridaAges 18 years+
Where these studies are running in Florida
Institutions with a site for the recruiting recurrent glioblastoma, idh-wildtype studies listed above.
- Mayo Clinic · 3 studies
- UM Sylvester Comprehensive Cancer Center at Coral Gables · 2 studies
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach · 2 studies
- University of Miami · 2 studies
- H. Lee Moffitt Cancer Center and Research Institute
- RecioMed Clinical Research Network, Inc.
- Sylvester Comprehensive Cancer Center at Hollywood
- Sylvester Comprehensive Cancer Center at Plantation
What taking part in a recurrent glioblastoma, idh-wildtype study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Recurrent Glioblastoma, IDH-Wildtype trials in other states
Common questions
- Are there recurrent glioblastoma, idh-wildtype clinical trials in Florida?
- Yes. We're currently tracking 5 recruiting recurrent glioblastoma, idh-wildtype studies with a site in Florida, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a recurrent glioblastoma, idh-wildtype study in Florida?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Florida to take part?
- Not necessarily. These studies have a site in Florida, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a recurrent glioblastoma, idh-wildtype trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New recurrent glioblastoma, idh-wildtype studies open in Florida regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.